Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward

Basit Öğe Kaydı
dc.contributor.authorCeylan, Cengizhan
dc.contributor.authorSancar, Mesut
dc.contributor.authorBeceren, Ayfer
dc.contributor.authorDemir, Ali
dc.contributor.authorKus, Coskun
dc.contributor.authorOmurtag, Gulden Zehra
dc.date.accessioned2024-02-23T14:34:23Z
dc.date.available2024-02-23T14:34:23Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractIntegrating clinical pharmacists in a multidisciplinary patient care team improves the treatment process by identifying and resolving drug-related problems (DRPs). The aim of the study was to determine the effect of clinical pharmacist intervention for DRPs in the gastroenterology service. The first period of the study was conducted between 15.06.2018 and 15.02.2019. Eighty patients admitted to the gastroenterology ward, who used at least one medication, were included in 'the study group'. The clinical pharmacist participated in ward rounds and made interventions to solve identified DRPs. In the second period of the study, the control group consisted of 80 patients admitted to the same ward between 01.03.2019 and 06.06.2019. DRPs were determined only from the data obtained from the hospital system in the control group. DRPs were classified according to the European Pharmaceutical Care Network (PCNE V9.1). A total of 136 and 46 with an average of 1.7 and 0.57 DRPs per patient (p <= 0.01) were identified in the study and control groups, respectively. Of the DRPs in the study group, 59 were related to treatment effectiveness, while 61 were related to treatment safety. Likewise, 21 DRPs were related to treatment effectiveness in the control group, while 12 were related to treatment (p <= 0.01). 65% of the interventions were made at the physician level and 49% at the drug level. 97% (n=133) of the total interventions were accepted. The number of DRPs was significantly reduced in the control group within the time frame after the clinical pharmacist intervention period. In conclusion, clinical pharmacists' importance in detecting and preventing DRPs in the gastroenterology ward has been demonstrated.en_US
dc.identifier.doi10.29228/jrp.166
dc.identifier.endpage696en_US
dc.identifier.issn2630-6344
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85130744082en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage687en_US
dc.identifier.urihttps://doi.org/10.29228/jrp.166
dc.identifier.urihttps://hdl.handle.net/20.500.12452/15585
dc.identifier.volume26en_US
dc.identifier.wosWOS:000799604300024en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherMarmara Univen_US
dc.relation.ispartofJournal Of Research In Pharmacyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectClinical Pharmacisten_US
dc.subjectDrug-Related Problemsen_US
dc.subjectGastroenterologyen_US
dc.subjectMedication Reviewen_US
dc.titleEvaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology warden_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu